Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Adma Biologics Inc (NASDAQ: ADMA) closed the day trading at $17.27 up 4.98% from the previous closing price of $16.45. In other words, the price has increased by $4.98 from its previous closing price. On the day, 4.94 million shares were traded. ADMA stock price reached its highest trading level at $17.295 during the session, while it also had its lowest trading level at $16.54.
Ratios:
For a better understanding of ADMA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.62 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 60.40. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 6.87. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.74.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 14 ’24 when Grossman Adam S sold 100,000 shares for $10.72 per share. The transaction valued at 1,071,980 led to the insider holds 2,081,475 shares of the business.
ELMS STEVE sold 411,829 shares of ADMA for $2,503,920 on Mar 19 ’24. The Director now owns 2,115,671 shares after completing the transaction at $6.08 per share. On Mar 18 ’24, another insider, ELMS STEVE, who serves as the Director of the company, sold 49,887 shares for $6.01 each. As a result, the insider received 299,821 and left with 2,527,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4025343744 and an Enterprise Value of 4078494464. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 122.83, and their Forward P/E ratio for the next fiscal year is 26.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.19 while its Price-to-Book (P/B) ratio in mrq is 21.38. Its current Enterprise Value per Revenue stands at 12.35 whereas that against EBITDA is 42.89.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $17.04, while it has fallen to a 52-week low of $3.06. The 50-Day Moving Average of the stock is 45.77%, while the 200-Day Moving Average is calculated to be 143.36%.
Shares Statistics:
Over the past 3-months, ADMA traded about 3.52M shares per day on average, while over the past 10 days, ADMA traded about 5123280 shares per day. A total of 226.06M shares are outstanding, with a floating share count of 225.11M. Insiders hold about 3.42% of the company’s shares, while institutions hold 74.32% stake in the company. Shares short for ADMA as of 1722384000 were 8746967 with a Short Ratio of 2.48, compared to 1719532800 on 7268371. Therefore, it implies a Short% of Shares Outstanding of 8746967 and a Short% of Float of 3.8699999999999997.
